1
|
Kayesh H, Islam MS, Wang J, Ohira R, Wang Z. SCAN: A shared causal attention network for adverse drug reactions detection in tweets. Neurocomputing 2022. [DOI: 10.1016/j.neucom.2022.01.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
2
|
Analysis of the Full-Size Russian Corpus of Internet Drug Reviews with Complex NER Labeling Using Deep Learning Neural Networks and Language Models. APPLIED SCIENCES-BASEL 2022. [DOI: 10.3390/app12010491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The paper presents the full-size Russian corpus of Internet users’ reviews on medicines with complex named entity recognition (NER) labeling of pharmaceutically relevant entities. We evaluate the accuracy levels reached on this corpus by a set of advanced deep learning neural networks for extracting mentions of these entities. The corpus markup includes mentions of the following entities: medication (33,005 mentions), adverse drug reaction (1778), disease (17,403), and note (4490). Two of them—medication and disease—include a set of attributes. A part of the corpus has a coreference annotation with 1560 coreference chains in 300 documents. A multi-label model based on a language model and a set of features has been developed for recognizing entities of the presented corpus. We analyze how the choice of different model components affects the entity recognition accuracy. Those components include methods for vector representation of words, types of language models pre-trained for the Russian language, ways of text normalization, and other pre-processing methods. The sufficient size of our corpus allows us to study the effects of particularities of annotation and entity balancing. We compare our corpus to existing ones by the occurrences of entities of different types and show that balancing the corpus by the number of texts with and without adverse drug event (ADR) mentions improves the ADR recognition accuracy with no notable decline in the accuracy of detecting entities of other types. As a result, the state of the art for the pharmacological entity extraction task for the Russian language is established on a full-size labeled corpus. For the ADR entity type, the accuracy achieved is 61.1% by the F1-exact metric, which is on par with the accuracy level for other language corpora with similar characteristics and ADR representativeness. The accuracy of the coreference relation extraction evaluated on our corpus is 71%, which is higher than the results achieved on the other Russian-language corpora.
Collapse
|
3
|
Liang L, Hu J, Sun G, Hong N, Wu G, He Y, Li Y, Hao T, Liu L, Gong M. Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources. Drug Saf 2022; 45:511-519. [PMID: 35579814 PMCID: PMC9112260 DOI: 10.1007/s40264-022-01170-7] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/27/2022] [Indexed: 01/28/2023]
Abstract
With the rapid development of artificial intelligence (AI) technologies, and the large amount of pharmacovigilance-related data stored in an electronic manner, data-driven automatic methods need to be urgently applied to all aspects of pharmacovigilance to assist healthcare professionals. However, the quantity and quality of data directly affect the performance of AI, and there are particular challenges to implementing AI in limited-resource settings. Analyzing challenges and solutions for AI-based pharmacovigilance in resource-limited settings can improve pharmacovigilance frameworks and capabilities in these settings. In this review, we summarize the challenges into four categories: establishing a database for an AI-based pharmacovigilance system, lack of human resources, weak AI technology and insufficient government support. This study also discusses possible solutions and future perspectives on AI-based pharmacovigilance in resource-limited settings.
Collapse
Affiliation(s)
- Likeng Liang
- School of Computer Science, South China Normal University, Guangzhou, China
| | - Jifa Hu
- The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Gang Sun
- Key Laboratory of Oncology of Xinjiang Uyghur Autonomous Region, The Affiliated Cancer Hospital of Xinjiang Medical University, Ürümqi, China
| | - Na Hong
- Digital Health China Technologies Co., Ltd., Beijing, China
| | - Ge Wu
- Digital Health China Technologies Co., Ltd., Beijing, China
| | - Yuejun He
- Digital Health China Technologies Co., Ltd., Beijing, China
| | - Yong Li
- School of Computer Science, South China Normal University, Guangzhou, China
| | - Tianyong Hao
- School of Computer Science, South China Normal University, Guangzhou, China
| | - Li Liu
- Institute of Health Management, Southern Medical University, Guangzhou, China
| | - Mengchun Gong
- Institute of Health Management, Southern Medical University, Guangzhou, China
| |
Collapse
|